In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...